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1. Introduction
1.1. Age-related macular degeneration
Age-related  macular  degeneration  (AMD)  is  a  progressive  retinal  degeneration  that  is
untreatable in up to 90% of patients and is the leading cause of blindness in the elderly
worldwide [1]. Although much effort is invested in understanding this condition, there is
neither a cure nor a way to prevent it, and treatment options are very limited. AMD affects
30% of  people  age  70  or  older,  and 60  million people  worldwide are  affected.  Over  10
million people are affected in the United States and it is estimated that more than 300,000
new cases are diagnosed annually [2-4]. Since persons over 60 represent the fastest growing
segment of the population, AMD will remain a significant public health problem for the
foreseeable future [5,6].
AMD is a multifactorial disease with age, systemic health, genetic and environmental risk
factors influencing disease progression [7, 8]. The most important pathogenic factors leading
up to AMD include oxidative stress, inflammation, and local production of angiogenic factors
[9]. A substantial body of literature suggests a role for oxidant injury to the RPE and local
inflammation as putative mechanisms in the pathogenesis of AMD [10-12]. However, to date,
little is known about the molecular signal(s) linking oxidation to inflammation in this late-
onset disease.
In AMD loss or dysfunction of retinal photoreceptors is the ultimate cause of vision loss.
However, the initial pathogenic target of AMD is the retinal pigment epithelium (RPE),
Brusch’s membrane (BrM), and choriochapillaris [13,14]. Clinical manifestations of AMD may
present in early or a late form [15]. In early AMD (commonly known as dry degeneration) (Fig.
1B), variuos lipic-derived and protein-rich extracellular deposits, known as drusen, accumu‐
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late under the RPE (Fig. 2) [14-16]. Ultimately, early AMD can progress to the late form of the
disease; geographic atrophy (commonly known as advanced dry AMD) (Fig. 1C) or neovas‐
cular AMD (commonly known as wet or exudative AMD) (Fig. 1D). Geographic atrophy is
characterized by death of RPE and photoreceptors (Fig. 1C) [14,15].
Figure 1. Fundus Photographs in health, early age-related macular degeneration (AMD), late forms of atrophic AMD
and neovascular AMD. The ocular fundus of a healthy eye, showing normal pigmentation and retinal blood vessels
(A). Drusen (thick arrows), seen as multiple discrete round yellow sub-retinal pigment epithelium (RPE) deposits, are
the first sign of early AMD (B). Atrophic AMD (C) is characterized by a window defect (thin arrows) with loss of RPE
and overlying photoreceptors. Neovascular AMD (D) is characterized by choroidal neovascularization (CNV), which is
prone to fluid exudation, hemorrhage, and fibrosis. The late-stage dry form of AMD, known as geographic atrophy.
Note large regions of depigmentation, especially in the macula, which is at the center of the image.(C) In wet AMD,
leaky blood vessels from the choroid invade the overlying retina.
Neovascular AMD is characterized by the growth of new abnormal blood vessels, with leaky
walls, under the RPE from the subjacent choroid, resulting in choroidal neovascularization
(CNV) and subsequent dysfunction or death of the overlying neurosensory retina [14,15].
Neovascular AMD progresses much more rapidly than early AMD and leads to a greater loss
of central vision. What both forms have in common, however, is pathology at the RPE/choroid
interface, which includes a thickening of BrM, due to the deposition of extracellular material
between the RPE and BrM (sub-RPE deposits and drusen) (Fig. 2). This review will focus on
the pathobiology of the early AMD by exploring the role of cigarette smoking and hypertension
in the onset and development of the disease.
Figure 2. Schematic image of the RPE-Bruch’s membrane-choriocapillaris interface in AMD. Basal laminar deposits
(BLD; **) appear between the RPE cell and the RPE basement membrane, while basal linear deposits (BlinD; *) localize
at the inner collagenous layer beneath the RPE basement membrane. Arrowhead indicates endothelial cell basement
membrane.
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2. The outer retina and choroid
As mentioned above, the pathology at the RPE/choroid interface, which includes deposition
of extracellular material between the RPE and BrM, is what both AMD forms have in common.
BrM undergoes several biochemical and anatomical changes with aging, including collage‐
nous thickening, calcification, and lipid infiltration, in the absence of apparent retinal dys‐
function [17,18]. The accumulation of specific deposits under the RPE is the hallmark
histopathological feature of eyes with early AMD, when visual function is still not irreversibly
impaired [14,19].
The RPE is a monolayer of hexagonally arranged, highly pigmented cells, located between the
neural retina and the choroid, and forming part of the blood-retina barrier (Fig. 3). Its many
functions include; the absorption of light that did not get captured by the photoreceptor outer
segment pigments; epithelial transport of molecules (nutrients, ions, water, and metabolites)
between the subretinal space and the choroidal blood supply; spatial ion buffering; re-
isomerization of the chromophore 11-cis-retinal from all-trans retinal; the daily removal of
photoreceptor outer segments by phagocytosis; the secretion of molecules such as growth
factors, proteases, and others that control the stability of the photoreceptor cells, BrM and the
choroid; and finally, the modulation of the immune response, since the RPE participates in
control of the immune privilege in the healthy eye or the mounting of an immune response in
the diseased eye [20]. Abnormalities in any of these processes might participate in RPE cell
pathology.
Figure 3. Schematic image of the photoreceptors-RPE-Bruch’s membrane-choriocapillaris interface and drusen in
AMD.
BrM occupies a crucial interface between the RPE and choroid and contains the basement
membrane of both the RPE and choroid (Fig. 3). BrM is traditionally considered to be a five-
layered stratified extracellular matrix that provides structural support to the overlying RPE
and retina [6,18,21]. BrM also provides a semipermeable filtration barrier through which major
metabolic exchange takes place between the RPE and the choriocapillaris. In the center of BrM
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is the elastic fiber layer (Fig. 3) sandwiched between the inner and outer collagenous layers.
Finally, two basal laminas define the innermost and outermost layers. The innermost layer is
the basal lamina of the RPE; the outermost layer is formed by the basement membrane of the
endothelial cells that comprise the choriocapillaris [6,18,21]. The collagen layers contain
striated collagen fibers mainly type I, III, and V [6,18]. Type I confers tensile strength to the
tissue, type III is normally present in tissues with elastic properties, and type V acts to anchor
basement membranes to stromal matrixes [17,18]. The interfiber matrix of BrM is comprised
largely of glycosaminoglycans such as heparan sulfate (25%) and chondroitin/dermatan sulfate
(75%). These provide an electrolytic barrier to diffusion and serve important regulatory roles
by binding extracellular proteins and growth factors that are vital for cellular processes such
as adhesion, migration, and differentiation [17,22,23].
The basement membrane of both the choriocapillaris and RPE are comprised of mostly type
IV collagen [17,18]. The basement membranes additionally contain laminin, heparan sulfate,
proteoglycans, and fibronectin. The outermost basal lamina also incorporates type VI collagen,
which is associated with the choriocapillaris [17,18]. It has been suggested that this collagen
may act to anchor fenestrated capillaries to the underlying choroid.
3. Subretinal deposit formation and progression: Pathogenic mechanisms
The accumulation of specific deposits under the RPE is a very prominent histopathologic
feature of eyes with AMD [24-27]. Sub-RPE deposits were first described nearly 160 years ago
and were generically termed “drusen” when observed by ophthalmologists upon clinical
examination of the retina [28]. Histopathological examination defines three main types of sub-
RPE deposits on the basis of thickness, content, and locationt: a) basal laminar deposits (BLD),
b) basal linear deposits (BLinD), and c) nodular drusen [14,29,30]. BLD and BLinD are both
diffuse deposits that accumulate on opposite sides of the basal lamina of the RPE (Fig. 2);
therefore, the RPE basement membrane is the crucial dividing line that demarcates the location
of BLD from BLinD [14]. BLD is seen as amorphous material of intermediate electron density
between the plasma membrane and the basement membrane of the RPE, often containing
wide-spaced collagen, patches of electron-dense fibrillar or granular material, and occasion‐
ally, membranous debris [31]. They are distributed throughout the retina, including the
periphery as well as the macula, underlying not only cones but rods as well. BLinD are diffuse,
amorphous accumulations within the inner collagenous zone of BrM, external to RPE basement
membrane (Fig. 2), with similar content variations [14]. BLinD are characterized by coated and
non-coated vesicles as well as some membranous and empty profiles [14]. Biochemically,
deposits contain phospholipids, triglycerides, cholesterol, cholesterol esters, unsaturated fatty
acids, peroxidized lipids, and apolipoproteins [24-26].
Nodular drusen are discrete, dome-shaped deposits within the inner collagenous zone of BrM
(i.e., external to the RPE basal lamina), which are often contiguous with BLinD, and can be
difficult to distinguish from BLinD without electron microscopy [5]. Nodular drusen may also
specifically contain vitronectin, immunoglobulins, amyloid, complement, and proteins
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associated with RPE cell function [32] as well as other poorly characterized components
[24-27]. Further, low-grade monocyte infiltration within the choriocapillaris is often present
underlying areas of deposits [25,27,33].
Clinically, deposits of AMD are classified on fundoscopic features of morphology and size [24].
Although multiple classifications exist, most clinicians use size to classify drusen: small or
“hard” (<63 μm) and soft, intermediate (>63 to <125 μm) and large (>125 μm) drusen [24]. When
hard or soft drusen coalesce to the point of losing their boundaries they are then classified as
“diffuse.” Although diagnosis of AMD is typically made when intermediate or large drusen
are present, the diagnosis can be also be made in the absence of drusen based on the presence
of pigmentary changes indicative of RPE degeneration [3,29,30]. The specific contribution of
drusen to AMD complications and progression are not well characterized, but the presence of
macular drusen is considered a strong risk factor for the development of both forms of late
AMD, geographic atrophy and neovascular AMD [3,34,35]. In general, eyes with clinical AMD
have been found to express all three deposit subtypes [14,25,36]. Furthermore, histological,
immunohistochemical, and ultrastructural studies of surgically-excised choroidal neovascular
(CNV) membranes have shown that the cellular and extracellular constituents of CNV are the
same regardless of the underlying disease, with the exception of the amount of BLD and the
presence of BLinD, which is virtually exclusively found in CNV specimens from patients with
AMD [29,37].
The cellular and molecular events involved in drusen formation have not been fully elucidated.
Lack of scientific consensus exists regarding the origin of drusen, but at least five different
paradigms are currently proposed to explain deposit formation in AMD; a) genetic hypothesis,
b) lysosomal failure/lipofuscin hypothesis, c) choroidal hypoperfusion hypothesis, d) barrier
hypothesis, and e) RPE injury hypothesis. Because our research is based on the RPE injury
hypothesis, in this section this theory is reviewed in light of the more recent finding.
There are a number of direct and/or indirect lines of evidence supporting a role for the RPE
in drusen biogenesis.  According to  traditional  models  of  drusen formation,  any cellular
material residing within drusen is predicted to be of RPE origin. Indeed, RPE-derived basal
laminae, organelles and cellular fragments, and even entire cells can be detected in early
“drusen”.  Some  authors  have  described  the  appearance  of  RPE  “debris”  blebbing  into
drusen  or  pre-drusen  sites  [38].  RPE  constituents,  such  as  basal  laminae,  as  well  as
lipofuscin  and  melanin  granules,  are  observed  within  early  drusen,  where  they  likely
contribute to drusen volume and formation.
The theory that drusen were derived from damaged RPE was originally postulated by
Donders, who first described drusen in a post-mortem eye, believed that drusen were derived
from RPE nuclei, based on the supposition that the latter are relatively resistant to degradation
[39]. Donders’ theory was later modified by De Vicentis (1887) who proposed that degenerative
change in the RPE cytoplasm, rather than in the nucleus, was the precipitating event. On the
other hand, Muller (1856) proposed that drusen result from aberrant secretion of basement
membrane components by the aged RPE [40].With the advent of electron microscopy, the
substructural features of drusen were revealed, and new variants of the earlier theories were
advanced. Some investigators have concluded, that drusen are formed when the RPE expels
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portions of its basal cytoplasm into BrM [38], possibly as a mechanism for removing damaged
cytosol [41] or as a byproduct of phagocytic degradation [19]. Others have postulated that
drusen are formed by autolysis of the RPE, due to aberrant lysosomal enzyme activity [42],
although enzyme histochemical studies failed to demonstrate the presence of lysosomal
enzymes in drusen [43]. Additional mechanisms for drusen formation, including lipoidal
degeneration of the RPE, have been proposed [44,45].
In the modern version, the RPE injury hypothesis proposes that deposit formation is secondary
to chronic, repetitive but nonlethal RPE injury [46, 47]. Two separate phenomena must be
distinguished: the injury stimulus and the cellular response. The most widely implicated injury
stimuli are various oxidants, especially those induced by RPE exposure to visible light or those
derived from endogenous metabolism [48,49]. More recently, inflammatory-derived injury
stimuli have also become implicated, including oxidants, complement, immune complexes
and factors produced by macrophages or monocyte [50-52]. Inflammatory cells might be
responsible for drusen progression into CNV by secretion of growth factors and cytokines that
will damage the choriocapillaris and stimulate the invasion of neovessels into the subretinal
space [37,51,52].
Irrespective of the injury, this model proposes that all stimuli result in a final common pathway
of cellular responses that cause the actual deposits. Cellular responses that can lead to deposit
formation include RPE cell membrane blebbing and dysregulation of extracellular matrix
(ECM) production and breakdown. Accumulation of sub-RPE blebbed material in the setting
of imbalanced breakdown and resynthesis of basement membrane and BrM ECM is proposed
to produce the various deposits of AMD. Repetitive injury ultimately can kill RPE, leading to
late dry AMD [6].
4. Hypothetical model for dry AMD and its progression to wet AMD
Our research is based on the RPE injury hypothesis (Fig. 4). Oxidative injury-mediated non
lethal RPE membrane blebbing, dysregulation of ECM turnover, inflammation, and angio‐
genesis appear to be key cellular processes that play a central role in the formation and
progression of sub-RPE deposits. We postulate that the pathogenesis and progression of dry
AMD is characterized by the following stages: (A) Initial RPE oxidant injury causes extrusion
of cell membrane “blebs,” together with decreased activity of matrix metalloproteinases
(MMPs), promoting bleb accumulation under the RPE as BLD. Numerous endogenous or
exogenous oxidants can induce blebbing; (B) RPE cells are subsequently stimulated to increase
synthesis of MMPs and other molecules responsible for extracellular matrix turnover (i.e.,
producing decreased laminin and collagen), affecting both RPE basement membrane and BrM
[46,53,54]. This process leads to progression of BLD into BLinD and drusen by admixture of
blebs into BrM, followed by the formation of new basement membrane under the RPE to trap
these deposits within BrM [55,56]. We postulate that various hormones and other plasma-
derived molecules related to systemic health cofactors are implicated in this stage [57-60]. (C)
Altered macrophages recruitment to sites of RPE injury and deposit formation. Macrophage
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recruitment may be beneficial or harmful depending upon their activation status at the time
of recruitment [50,61]. Nonactivated or scavenging macrophages may remove deposits
without further injury. Activated or reparative macrophages, through the release of inflam‐
matory mediators, growth factors, or other substances, may promote complications and
progression to the late forms of the disease [37,50,62,37]. As discussed below, the effect of
cigarette smoking and Ang II in the mentioned stages will be reviewed in depth.
Figure 4. Schematic drawing of the early stages of age-related macular degeneration (AMD). First stage: Oxidant in‐
jury at the retinal pigment epithelium (RPE) causes bleb formation and decreased matrix metalloproteinases (MMPs).
Blebs than accumulate between the RPE and the basement membrane as basal laminar deposits (BLDs). Second stage:
Increased matrix turnover characterized by increased MMPs and decreased collagens. BLDs progress into basal linear
deposits (BLinDs) and drusen and are located within the inner collagenous layer of Bruchs membrane. Third stage:
Macrophages recruited to the site of injury by chemotactic factors are responsible for release of cytokines, angiogenic
factors, and oxidants that perpetuate RPE injury and lead to late stages of AMD. Abbreviations: MPO = myeloperoxi‐
dase; NF-κB = nuclear factor kappa-light-chain-enhancer of activated B cells; TNF-α: tumor necrosis factor-alpha;
MCP-1: monocyte chemotactic protein-1; VEGF: vascular endothelial growth factor.
5. Smoking and age-related macular degeneration
It has been postulated that environmental oxidants are frequently implicated in RPE injury
and may contribute to deposit formation. Cigarette smoking is the strongest environmental
risk factor for all forms of AMD, even in people exposed to passive smoking [63-66]. People
who have smoked at least 100 cigarettes (lifetime) have approximately triple risk of developing
AMD compared to individuals who have never smoked. Current smokers and heavy smokers
have even higher AMD risk.
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Cigarette smoke is comprised of a gas and tar phase. Each phase contains both inorganic and
organic free radicals, including ROS, epoxides, peroxides, NO, nitrogen dioxide, peroxynitrite,
peroxynitrates and various other free radicals [67]. Moreover, cigarette smoke contains a high
concentration of potent oxidants such as acrolein [68-70], dioxin [71], Benzo(a)Pyrene [72],
cadmium, [73-75] quinones, nicotine, and NO [76-79]. Many of them demonstrated to be toxic
to ocular tissue affecting the eye through oxidative damage and abnormal vascularization.
Although the pathogenesis of AMD and the mechanism of action of smoking on the eye are
not fully understood [80], the risk of developing AMD is likely to involve more than one
mechanism.
Smoking habit appears to be related to the long-term incidence and progression of AMD
[81].  Plausible  biological  mechanisms  such  as  direct  oxidation,  depletion  of  antioxidant
protection (e.g. decreases plasma vitamin C and carotenoids), immune system activation,
atherosclerotic vascular changes, induction of hypoxia and alteration of choroidal blood flow
[82,83], support the involvement of smoking in the etiology of AMD [84]. Interestingly, the
Age-related Eye Disease Study (AREDS) [85] found that reduction in plasma glutathione and
cysteine oxidation correlated with benefit from anti-oxidant treatment for intermediate AMD
[86].  Collectively,  these  studies,  along  with  the  studies  on  cigarette  smoking,  implicate
oxidative stress as a mechanism of AMD. Genetic variations such as a susceptibility locus in
or near the hypothetical LOC387715 gene were associated with AMD [87,88]. It has been
reported that this locus encodes a mitochondrial protein, raising suspicion for a role of the
oxidative defense response in this disease. This locus is associated with smoking, and the
combination of the LOC387715 polymorphism and smoking confers a higher risk for AMD
than either factor alone [89,90]. Moreover, chemical in cigarette smoke modifies oxidative‐
ly  docosohexanoic  acid  (DHA),  the  most  abundant  fatty  acid  in  photoreceptor  tips,  to
carboxyethylpyrrole (CEP) [91] and other lipids which have been identified which “tag”
oxidatively oxidized damaged photoreceptors in AMD [92]. In the RPE, multiple proteins
isolated  from  lipofuscin  are  also  oxidatively  damaged  by  cigarette  smoke  compounds
including malondialdehyde, 4-hydroxynonenal and advanced glycation end products (AGE)
[93,94]. Interestingly, AGEs accumulate in BrM including basal deposits and drusen, and
CEP adducts appear in drusen isolated from AMD samples [95,96].The ability to defend
against oxidative stress by upregulating the anti-oxidant defense response is likely to be a
pivotal event that mediates the initiation and progression of AMD. The molecular damage
from oxidative modification illustrated here, suggests that the anti-oxidant response in the
macula at some point, becomes unable to neutralize oxidative stress.
In addition to direct oxidative damage to tissue, oxidative free radicals from cigarette smoke
can modulate the immune-inflammatory system in part, through enhanced expression of pro-
inflammatory genes, as reviewed in Biswas and Rahman (2009) [97]. The discovery of poly‐
morphisms in several complement factors with AMD susceptibility points toward a specific
role for complement mediated inflammation in the pathophysiology of AMD [98,99]. AMD
has been associated with local inflammatory responses in the RPE/choroid [100]. In previous
works, it was demonstrated that the aged RPE/choroid becomes immunologically active [101]
due to increased expression of complement components. Smoking also influences the function
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of the alternative pathway of complement activation [121]. Smoking seems to alter the C3
component of the complement and to reduce the efficacy by which it binds to complement
factor H (CFH).
The association between smoke and ApoE has also been investigated. Smokers are known to
have higher serum cholesterol and LDL levels, a possible risk factor for AMD development
[102]. Impaired cholesterol metabolism in particular ApoE isoforms carriers could be further
enhanced among smokers. Moreover, smoking is associated with decreased endothelial NO
production, while ApoE-4 genotype has been reported to increase NO synthesis, relative to
ApoE2 and ApoE3 [103]. Thus, the presence of the ApoE2 protein in smokers may reduce
endothelial NO levels in cell tissues. Given that the normal function of NO in the retina is to
neutralize circulating oxidized lipids, its decreased availability may promote oxidative
damage to the RPE cells.
As mentioned above, quinones, acrolein, BenzoPyrenes, and cadmium can damage the eye
through oxidative processes. It has been demonstrated that hydroquinone the most abundant
quinone in cigarette smoke causes oxidative damage, apoptosis, increases lipid peroxidation
and mitochondrial superoxide production, and decreases intracellular glutathione in the RPE
cells [104]. Acrolein, a product of lipid peroxidation in vivo, is a mitochondrial toxicant in RPE
cells, which induces oxidative mitochondrial dysfunction and oxidative damage to proteins
and DNA causing loss of cell viability [70-72]. Whereas Benzo(a)Pyrene causes mtDNA
damage, alteration in the lysosomal activity, complement activation in the aged RPE, and
upregulates expression of complement pathway components such as C3a, C5, C5b-9, and CFH
in the RPE/choroid contributing to drusen formation [105,106]. Cadmium (Cd), is another toxic
which is concentrated in the body through cigarette smoke. Cd has been demonstrated to be
a potent inflammatory, an oxidant agent, and accumulates with aging, effects which are linked
to AMD [77, 107]. In vitro studies have revealed Cd as an important potential factor in RPE
cell death associated retinal disease [76].
Cigarette smoke also induces angiogenesis promoting CNV and progression to neovascular
AMD. Nicotine is one of the major components of the cigarette and has been demonstrated to
enhance the generation of radical oxygen species producing oxidative stress [108-110] and
promote the generation of pro-inflammatory responses leading to chronic inflammation in
smokers [111]. Futhermore, nicotine is responsible for the mitogenesis of endothelial and
smooth muscle cells [112] regulating abnormal responses to vascular injury [113] and endo‐
thelial functions [114]. We and other previously showed that nicotine by its direct action on
nicotinic receptors promoted angiogenesis and increased size and severity of CNV in a mouse
model [112, 114]. Moreover, it has been shown that nicotine targets the retinal microvasculature
by reducing the apoptotic rate of vascular endothelial cells and inducing the formation of new
capillarity, mediated at least in part by release of vascular endothelial growth factor (VEGF)
[113], which is one of the key growth factors involved in neovascularization and implicated in
the most severe form of AMD [115-118]. Nicotine has also the ability to stimulate the growth
of smooth muscle cells after oxidative injury, leading to the development of CNV in the retina.
Moreover other cigarette smoke components such as dioxin induce expression and release of
VEGF by RPE cells promoting CNV [104, 119].
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6. Hypertension and age-related macular degeneration
Even though age is the major determinant for developing AMD, clinical and epidemiolog‐
ic studies have suggested systemic vascular disease, especially hypertension, as an impor‐
tant risk factor for AMD [3,119] and a correlation between AMD and aging and hypertension
[3, 120]. Aging is the risk factor with the greatest correlation with incidence, prevalence and
severity  of  AMD,  but  the  age-related susceptibility  factors  remain  completely  unknown
[3,120]. However, increased sensitivity to the injurious effects of hypertension and to oxidant-
injury  are  all  more  severe  in  the  elderly  than in  the  young [121-123].  For  exemple,  the
interaction of Angiotensin II (Ang II) (the most important hormone associated with hyperten‐
sion)  with  AT1 receptors,  produces  ROS,  and with  advancing age,  oxidative  alterations
accumulate in cellular components, including those in the antioxidative defense systems,
due to disrupted redox regulation during aging can influence the gene transcription and
signal transduction pathways.
Hypertension is of particular interest among the systemic risk factors, due to its increasing
incidence in Western societies. In several cross sectional and case control studies, systemic
hypertension was associated with increased prevalence and progression of the severity and
incidence of drusen [124] and with the development of wet AMD [125-127]. Interestingly, a
recent study provides a strong association between hypertension and the development of
wet AMD in the presence of early AMD [128]. Despite of the apparent link between AMD
and hypertension, these studies make no mention of the mechanism(s) by which hyperten‐
sion may induce or contribute to the pathogenesis of dry AMD and its progression from
early AMD to CNV.
Traditionally,  hypertension is  believed to  contribute  to  chronic  diseases  by  at  least  two
distinct  mechanisms:  hemodynamic injury and humoral  factors [129-131].  Hemodynamic
injury refers to mechanical damage induced by flow turbulence in large vessels or stretch‐
ing of capillaries induced by increased blood pressure.  Humoral factors refer to cellular
activities induced by hormones or growth factors associated with hypertension [129,130]
shuch  as  Ang  II,  which  is  upregulated  in  hypertension,  present  in  the  blood  of  many
hypertensive patients and has been demonstrated to activate specific receptors to induce
various cellular functions. Ang II as the molecular surrogate for the effects of hypertension
in AMD, and its properties will be described below.
The classical view of the renin-angiotensin system (RAS) as a systemic regulator of blood
pressure has been extended, and a substantial number of studies have highlighted the
importance of local RAS in a variety of extra-renal tissues, including adrenal glands [132],
thymus [133] and recently in the eye [134,135]. In the eye, Ang II, and Ang II type 1 and type
2 receptors (AT1R, AT2R) have been found in the retina, particularly in the retinal pigment
epithelium (RPE) [59,60,136-139]. Similarly, studies in rat retinal tissues also suggested local
synthesis of both renin and angiotensin convertingenzyme (ACE) [140]. Along this line,
Milenkovic et al. (2010) demonstrated that the RPE expresses renin and secretes it towards the
retinal side. The presence of the most important RAS components in the retina implies a
physiological function of RAS within the eye. However, despite the considerable evidence for
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local RAS in the retina, its exact role and its possible relationship with the systemic RAS remain
poorly understood. The fact that AT1R is localized at the basolateral membrane of the RPE,
which faces the blood side of the epithelium, suggests that the activity of the systemic RAS is
a part of that signaling. Interestingly, it has been shown that modulation of the systemic RAS
(e.g. by systemic application of ACE inhibitors) changes neuronal activity within the retina,
mainly of bipolar cells and amacrine cells as monitored by electroretinography [139,141,142].
Moreover, modulators of the systemic RAS alter renin expression in the RPE [138] and plasma
Ang II can not cross the intraocular space [143] suggesting that the systemic RAS most likely
influences the intraocular RAS through the RPE.
Ang II mediates its biological effects through the activation of AT1R and AT2R receptors. It is,
however, through AT1R activation that Ang II elicits most of its well known effects, including
vasoconstriction, electrolyte homeostasis, fibrosis, inflammation and proliferation. In the eye,
AT1R activation has been implicated in the pathogenesis of many ocular disorders such as
diabetic retinopathy [144,145], neovascularization in hypoxic-induced retinopathies [146-148]
and age-related macular degeneration [59,60,149]. We postulate that the interaction of Ang II
with AT1R, one of the most important oxidative stress inducer: a) induces blebs formation
through reactive oxygen intermediate (ROS) production by activation of NADPH promoting
bleb accumulation under the RPE as BLD and b) increases MMP-2 activity, MMP-14, and
basigin, major mediator of ECM turnover through MAPK phosphorylation, and pro-inflam‐
matory monocyte chemoattractant protein-1 (MCP-1) production through NF-kB activation
by RPE stimulating RPE basement membrane breakdown and infiltration of pro-inflammatory
macrophages to sub-RPE deposit areas, where they will scavenge, release inflammatory
mediators, growth factors or other substances, which may promote complications and
progression to CNV [37,51,62]. Moreover, we propose that Ang II decreases TNFSF15, an anti-
angiogenic cytokine expressed in inflammatory diseases, altering the balance between
TNFSF15 and VEGF required for normal angiogenesis.
7. Oxidative injury to the RPE
As mentioned previously, a substantial body of literature suggests a role for oxidant injury to
the RPE as a putative mechanism in the pathogenesis of AMD and addresses the protective
actions of anti-oxidant. Although intuitively obvious, oxidant injury can induce either lethal
responses, leading to cell death, or nonlethal responses inducing a functional change from
baseline compatible with continued life of the cell but leading to dysfunction of the tissue or
organ. Most studies focus on oxidant-mediated death of RPE [150-153]. Yet, RPE death (so-
called geographic atrophy) is a very late stage of dry AMD, resulting from a very chronic and
progressive process. Subretinal deposits and thickening of BrM, the hallmarks of early AMD,
develop decades before the RPE cells actually die. Therefore, nonlethal cellular responses to
RPE oxidant injury must contribute to early AMD.
Oxidative modifications in key cellular molecules such as DNA, carbohydrates, cellular
proteins and cell membranes can often produce a cytotoxic chain reaction that contributes to
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the pathogenesis of many diseases [154-156]. However, we believe that oxidative damage to
cell membranes and cellular proteins is more important in AMD.
RPE cell membranes are highly susceptible to lipid peroxidation. Phospholipids in RPE and
photoreceptor membranes are especially rich in polyunsaturated fatty acid (PUFAs), including
the ω-3 fatty acid docosahexanoic acid and the ω-6 fatty acid arachadonic acid. The presence
of both types of PUFAs in phagocytosed photoreceptor outer segments renders the RPE cell
membrane especially susceptible to lipid peroxidation and blebbing [157,158]. Cellular
proteins are also important targets of oxidant-induced modification. Typical chemical modi‐
fications include breakdown of disulfide bonds, tyrosylation, acetylation and many other
biochemical changes that can alter function of the molecule [159]. Accordingly, several well-
described pathways exist to remove these damage biomolecules [160]. Although any cellular
protein is potentially susceptible, the actin cytoskeleton is especially vulnerable to oxidant-
induced damage.
Although oxidants derived from blue-light exposure, inflammation, or endogenous metabo‐
lism are more frequently implicated in RPE injury, we have also hypothesized that environ‐
mental toxicants and various hormones and other plasma-derived molecules related to
systemic health cofactors serve as oxidants to contribute to deposit formation. We embrace the
pathogenic paradigm based on the response-to-injury hypothesis which proposes that sub-
RPE deposits originate from RPE-derived cell membrane blebs and dysregulation of ECM
turnover induced by chronic nonlethal injury to the RPE in response to oxidative damage and
propose that cigarette smoking-related hydroquinone and Ang II-induced hypertension
contributes to the pathogeneis of AMD by causing oxidative damage to the RPE.
7.1. Nonlethal cell derived microparticles
Cell derived microparticles are considered to be microvesicles released through the process of
exocytic budding of the plasma membrane following stimulation of different cell types [161,
162]. There are two well-known cellular processes that can lead to the formation of micropar‐
ticles: chemicals and physical cell activation, and apoptosis [163,164]. Mild injuries inflected
to the retina elicit a cellular response in the RPE consisting in pinching off small areas of the
plasma membrane, which renders small microvesicles called blebs [165] (Fig. 5). The reason(s)
behind membrane blebbing remains unknown, although it has been postulated to be an
attempt to discard damaged cellular constituents by the RPE cell [14]. Nonlethal cell membrane
blebbing was first introduced 30 years ago as a possible pathogenic mechanism in drusen
formation [38, 166,167]. Blebbing is an early morphologic sign of cell injury which occurs
immediately after exposure to a wide variety of toxic agents. However this process is different
from lethal blebbing and apoptosis [168-170]. As mentioned previously, under prolonged
injury, blebs may accumulate between the RPE and the basal lamina underneath this cell
monolayer. Based on this concept, a plausible role for blebs in the pathogenesis of dry AMD
has been suggested as a likely contributor to build-up of the sub-RPE deposits, which are
characteristic of the early stages of this disorder [14].
Age-Related Macular Degeneration - Etiology, Diagnosis and Management - A Glance at the Future50
Figure 5. Plasma membrane microvesicles (blebs).
Figure 6. (a) Induction of membrane blebs in ARPE-19 cells by hydroquinone-induced cellular stress. ARPE-19 cells ex‐
pressing GFP at the plasma membrane (A) were exposed to HQ (100 μM) for 6 h (B). Cells were observed immediately
under epifluorescence microscope (magnification, ×40). The figure shows GFP localized to the membrane and the
presence of membrane blebs (white arrowheads) after HQ treatment. A detailed view of the blebs that accumulated
in the conditioned medium after HQ treatment is shown (C). (b) Induction of cellular changes in ARPE-19 cells by Ang
II. Fluorescent GFP-ARPE-19 derived blebs before and after exposure to Ang II (100 nM) alone or in combination with a
specific Ang II receptor antagonists AT1 (CD, 100 nM) or AT2 (PD 123319, 100 nM) for 24 hours. Cells were treated
and observed immediately under epifluorescent microscope. White arrows show GFP localized to the membrane.
White arrowheads show the presence of membrane blebs.
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Using a genetically modified human RPE cell line containing fluorescent protein anchored to
the inner leaflet of the plasma membrane, we demonstrated nonlethal blebbing in response to
oxidative stress. Bebbing can be induced by oxidant injury with blue light, myeloperoxidase
(MPO), hydroquinone (Monroy D., et al., IOVS, 2001, 42(4), ARVO Abstract, 4060; Suner I.J.,
et al. IOVS 2004; ARVO E-Abstract 1810) [56,171], or Ang II (Fig. 6). Today, however, RPE bleb
composition and potential functions remain largely unexplored.
Membrane bleb or microvesicle production stimulated by a variety of stress has been exten‐
sively described in many different cell types [172–178]. To gain a better understanding of the
functional relevance of blebs in general and the pathogenic mechanism(s) involved in early
AMD in particular, we investigated the identity of proteins carried by human RPE blebs. In
our study, we showed the proteomics characterization of stress-induced blebs in RPE cells
from human retina. We report identification of several proteins, some of them potentially
involved in MMP activation, membrane lipid raft formation, and immunogenic processes (Fig.
7) [179]. In our study, we intended to gain some insight into the functional characterization of
blebs to unravel some of the biological consequences of cell membrane blebbing in disease.
Figure 7. Isolation of blebs (left). A, scheme for bleb isolation. ARPE-19 cells were treated with HQ (100 μM) for 6 h.
Culture medium was collected and centrifuged at 100 × g for 15 min at 4 °C. The resulting pellet was washed twice
with PBS and resuspended. The resuspended pellet was centrifuged at 100 × g for 15 min at 4 °C, and the supernatant
was removed. Blebs were collected and used for protein extraction. B, representative one-dimensional gel showing
the Coomassie Blue and silver stainings of resolved proteins present in ARPE-19 blebs. Functional characterization of
proteins identified in hydroquinone-induced blebs (right). The distribution profile of the proteins identified in hydro‐
quinone-induced blebs is depicted according to functional categories. The KEGG database number and its corre‐
sponding metabolic pathway are shown. TCA, tricarboxylic acid cycle.
Blebbing are closely interrelated with the actin cytoskeleton [180-188]. The cytoskeleton is a
dynamic structure undergoing continuous turnover by disassembly and reassembly of G-actin
monomers, which are added to the active edge of a growing filament. Cytoskeletal turnover
is mediated by actin polymerizing protein system (APP), which is a large system of interacting
proteins. The identity of these proteins is a rapidly growing field, and includes kinases,
phosphatases, cleavage proteins, and elongating proteins. Their individual specific function
and regulatory interactions remain essentially unknown. However, in general, the APP
functions as a coordinated system such that individual molecular regulators of cytoskeleton
dynamics exert their actions on the entire APP in coordinated fashion [180-188].
Very little information is available regarding the molecules that regulate the APP system and
disease pathogenesis. Interestingly, oxidant injury is an effective activator of increased
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cytoskeleton turnover, presumably secondary to direct oxidative changes of disulfide bonds
within actin filaments [180, 189-192]. The best characterized inhibitor/ stabilizer of cytoskeleton
turnover is heat shock protein 25/27 (Hsp25/27). This molecule belongs to the family of small
heat shock proteins (which includes α-β crystallins) and serves a dual role as cytoskeleton
stabilizer and chaperone protein [191-193].
Oxidant injury can induce a rapid upregulation of Hsp25/27 protein through the activation of
presynthesized heat shock factors (hsf-1,-2,-3) which upon oxidation form trimers that become
very potent transcription factors [184-189]. Upon phosphorylation, Hsp25/27 acts as an F-actin
cap-binding protein, binding to the active edge of a growing microfilament, causing a transient
delay in actin cytoskeleton reassembly and repair [180,181,194,195]. Transient delay in
reassembly allows the unsupported plasma membrane to be forced outward by the hydrostatic
forces of the cytoplasm, and a vesicle or bleb forms if cortical cytoskeleton and microfilaments
do not completely reform within the outpouched membrane. Phosphorylation of Hsp25/27 is
mediated through the MAP kinase cascade, but is directly phosphorylated by MAPKAP 2
kinase (MK2), which in turn is phosphorylated by p38 kinase (Figure 4) [180, 196]. Thus,
oxidative stress induces profound rearrangements of the actin cytoskeleton [197, 189, 198]
leading to membrane blebbing through the activation of p38 mitogen activated protein kinase
(MAPK)//Heat shock protein 27 (Hsp27) pathway [190,198].
In response to stress, phosphorylated Hsp27 undergoes conformational changes and reorgan‐
izes into dimeric units [198-202]. Phosphorylated Hsp27 regulates actin filaments dynamics
by repressing the ability of Hsp27 to block actin polymerization [201]. Hsp27 phosphorylation
has been abundantly described in several human diseases [203]. Yet, there is a complete lack
of information regarding the possible association between phosphorylated Hsp27 and AMD.
Increased Hsp27 protein content along with evidence of cellular oxidative stress was reported
in human eyes with AMD, but Hsp27 phosphorylation was not investigated [204]. Therefore,
we believe that Hsp27 is an important mediator of RPE response to hydroquinone-induced
oxidative damage, which may contribute to injury-induced actin rearrangement and blebbing.
We studied the phosphorylation of Hsp27 in RPE from human eye donors and found that the
RPE constitutively express phosphorylated Hsp27, and that its expression is increased in
patients with dry AMD (Fig. 8) [205] providing novel evidence that phosphorylated Hsp27
may play a major role in the pathogenesis of AMD.
We reported that human RPE cells constitutively express high levels of Hsp27 which were
regulated by oxidative-mediated injury and that Hsp27 is expressed in extruded blebs
confirming that Hsp27 plays a role in actin filaments dynamics [205, 206]. We also addressed
the question whether hydroquinone-induced oxidative injury can activate different MAPK
pathways of any posttranslational modifications such as dimerization or phosphorylation of
Hsp27 known to regulate F-actin polymerization. Our previous observations were extended
by showing that exposure of RPE cells to cigarette smoke-derived hydroquinone non lethal
injury induces the transcriptional activation of Hsp27, accumulation of Hsp27 dimers and a
rapid phosphorylation of Hsp27 as well as actin rearrangements inton aggregates and
membrane blebbing (Fig. 9) [205]. These results together with the observation that SB203580,
a specific pharmacologic inhibitor of p38 kinase activity [207], efficiently blocked Hsp27
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Figure 8. Increased phosphorylated Hsp27 (p-Hsp27) expression in human RPE from patient donors with dry AMD. A:
Representative Western blot for p-Hsp27, total Hsp27 and GAPDH on RPE lysates from 3 donors with dry AMD and 3
controls with no known history of eye disease. B-G: Representative immunofluorescent double staining of p-Hsp27
(green) and nuclei (bleu) in retina sections from human donor eyes with no known eye disease (D), and human donor
eyes with dry AMD (E). Negative controls were generated by omission of the primary antibody (B, C). Higher magnifi‐
cation showing RPE and BrM in control (F) and AMD (G) patients. Sections were analyzed using confocal microscopy
(magnification x40 and x400). INL, inner nuclear layer; ONL, outer nuclear layer; PIS, photoreceptor inner segments;
POS, photoreceptor outer segments; RPE, retinal pigment epithelium; Ch, choroid; BrM, Bruch’s membrane.
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phosphorylation as well as actin cytoskeleton remodeling and blebs formation in response to
hydroquinone in RPE cells, strongly suggest that p38 MAPK pathways activation by hydro‐
quinone modulates F-actin aggregates formation and membrane blebbing through Hsp27
phosphorylation. Our findings are in agreement with prior studies reporting p38 MAPK
signaling pathway as an upstream mediator in oxidative stress-induced actin reorganization
and Hsp27 phosphorylation [190, 198-200, 208].
Figure 9. Inhibition of ERK MAPK pathway blocks hydroquinone (HQ)-induced Hsp27 phosphorylation and focal ag‐
gregates formation. A: Abrogation of HQ-induced Hsp27 phosphorylation by PD98059. Confluent serum-starved
ARPE-19 cells were pretreated for 1 hour with 40μM of ERK inhibitor PD98059 (PD), and then exposed to 100μM HQ
for 5 min. Total Hsp27, p-Hsp27 and GAPDH protein expression was evaluated by Western blot analysis. Top: Western
blot from a representative experiment. Numbers on the left represent protein molecular mass in kilodaltons (kD). p-
Hsp27 protein expression was normalized to total Hsp27 protein. Bottom: average densitometry results of three inde‐
pendent experiments run in duplicate. Data are expressed as percentage of control and are means ± SE. **p< 0.01
versus control; ##p< 0.01 versus HQ alone. B: Decreased formation of F-actin aggregates showed by staining for F-
actin in ARPE-19 cells pretreated for 1 hour with or without 40μM of PD and then exposed to 100μM HQ for 6 hours.
Cells were stained with rhodamine-phalloidin and examined by confocal microscopy using magnification x40. White
arrowheads show formation of focal aggregates. C: Quantification of F-acting aggregates from three independent ex‐
periments run in duplicate. Data are expressed as percentage of HQ-treated cells and are means ± SE. ***p < 0.001
versus HQ-treated cells.
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Several reports have shown that PP2A is involved in Hsp27 dephosphorylation [209, 210] and
that oxidative stress causes extracellular-signal-regulated kinases (ERK) phosphorylation and
reorganization of actin cytoskeleton in RPE cells [211]. Using okadaic acid as an inhibitor of
Hsp27 dephosphorylation by PP1 and 2A, we observed an increase in Hsp27 phosphorylation
in hydroquinone-stimulated RPE cells as well as F-actin reorganization and blebs formation
[205]. Moreover, we demonstrate that Hsp27 phosphorylation and F-actin aggregates forma‐
tion is almost completely abolished in cells transfected with siRNA against Hsp27 following
treatment with hydroquinone [205].
As mentioned above ERK cascade participates in numerous intracellular signaling pathways
in response to environmental stimuli, such as oxidative stress [211]. Our study also show that
treatment with hydroquinone led to a robust activation of ERK signaling pathway in ARPE-19
cells as well as in mice. These results together with the observation that PD98059, a specific
pharmacologic inhibitor of MEK, completely abolished Hsp27 phosphorylation as well as actin
cytoskeleton remodeling in response to hydroquinone, strongly suggest that ERK is also a key
upstream activator of hydroquinone-induced Hsp27 phosphorylation in RPE cells [205] (Fig
9). Our results not only showed that kinetics of p38 and ERK phosphorylation correlated well
with that of Hsp27, but also that Hsp27 phosphorylation and F-actin aggregates formation
were decreased after inhibition of either p38 or ERK signaling cascades. These observations
suggest that p38 as well as ERK MAPK pathways are required for the optimal activation of
Hsp27 leading to F-actin rearrangement and bleb formation in RPE cells in response to
hydroquinone. Taken together,these data establish; a) a direct correlation between levels of
phosphorylated Hsp27 and actin cytoskeleton reorganization in response to hydroquinone-
induced oxidative injury in human RPE cells; b) present ERK as a novel upstream positive
regulator of Hsp27 and actin aggregates formation in response to hydroquinone-induced
oxidative injury in RPE cells; and c) give support to a key role of phosphorylated Hsp27 in the
regulation of F-actin filaments dynamics and blebs formation following hydroquinone-
induced oxidative stress in RPE cells. Given that there is no effective treatment for dry AMD,
this study highlights Hsp27 as a potential, disease-related protein as well as biochemical
pathways for potential therapeutic strategies.
In addition to Hsp27/Hsp25, other important molecules such as small GTPases protein
superfamily (RAS and Ral) have been involved in the regulation of the actin polymerizing
protein system and oxidative stress [212,213]. Membrane blebbing is RhoA-, Rho kinase
(ROCK)-, and myosin light chain kinase (MLCK)-dependent, and blebs are devoid of actin,
mDia1 and Arp2/3 [214]. Rals are small G proteins that cycle between an active GTP-bound
state and an inactive GDP-bound state [215]. Ral GDP dissociation stimulator (RalGDS) was
found to be an effector of Ras [216-218] and highly specific for RalA and RalB, whereby it
facilitates the exchange of GDP for GTP on Rals [216,219,220]. Moreover, it has been demon‐
strated that RalGDS forms a cytosolic complex with β-arrestin, and that in response to formyl-
Met-Leu-Phe (fMLP) receptor stimulation, RalGDS is released from β-arrestin and translocates
to the plasma membrane.
RhoA is an additional small G protein that is implicated in regulating plasma membrane
dynamics. RhoA is activated by Ang II and is necessary for AT1 receptor-induced stress fiber
formation [221]. The proteins ROCK and mDia1 are both RhoA effectors and have been shown
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to play a role in changes in actin cytoskeletal reorganization. RhoA acts through ROCK to form
stress fibers [240], and ROCK has been shown to be involved in cell contraction induced by
Ang II [222]. mDia1 is a member of the ubiquitous formin protein family. These proteins are
activated by interaction with Rho GTPases and are then able to mediate actin polymerization
[223]. Overexpression of the GTP-Rho binding domain of mDia1 causes spontaneous mem‐
brane blebbing [224].
Ang II-stimulated membrane bleb formation involves RhoA. Furthermore, membrane
blebbing activated by Ang II through AT1 receptor activation is attenuated in the presence of
the β-arrestin amino-terminal domain, Ral GDP dissociation stimulator (RalGDS) β-arrestin
binding domain, and short interfering RNA (siRNA) depletion of β-arrestin2 [225]. In addition,
the inhibition of the downstream RhoA effectors ROCK and MLCK effectively attenuated AT1
receptor-mediated membrane blebbing. Thus, membrane blebbing in response to AT1 receptor
signaling was dependent on β-arrestin2 and was mediated by a RhoA/ROCK/MLCK-depend‐
ent pathway providing evidence that agonist stimulation of AT1 receptor leads to plasma
membrane blebbing responses by activation of RhoA and subsequent coupling to the ROCK/
MLCK pathway [225].
Cytoplasmic actin aggregates were observed after nonlethal blebbing, but not with lethal
oxidant injury. Interestingly, activation of the AT1 receptor with Ang II resulted in the rapid
formation of ROS and membrane blebs at early time points of Ang II stimulation that cease
within 60 min of Ang II stimulation (Marin-Castano., et al., IOVS, 2001, 42(4), ARVO Abstract,
4060). Further, Ang II-enhanced ROS production and blebbing was prevented by pre-treat‐
ment of RPE with the AT1 receptor blocker, which attenuates oxidative stress [226]. However,
RPE derived blebs after Ang II were bigger than those seem when RPE cells were exposed to
blue light, MPO, or hydroquinone. Moreover, formation of RPE-membrane blebs induced by
Ang II occurred earlier than with the other oxidants we studied. Therefore, we believe that
Rho-kinase pathway could be implicated as an important mediator of RPE response to Ang
II-induced oxidative damage instead of Hsp27/Hsp25/p38/ERK pathway.
In conclusion, characterization of the molecular mechanism(s) by which hydroquinone and
the AT1 receptor regulates the actin cytoskeleton and plasma membrane dynamics will be
essential for modulating the degree of blebbing in vitro and deposit formation in vivo for
potential therapeutic strategies.
Another injury response relevant to early AMD is imbalance in ECM turnover. The normal
anatomy and physiology of ECM in most tissues requires continuous turnover of matrix
components by a tightly regulated balance in the production of matrix molecules like collagen,
laminin, matrix metalloproteinases (MMPs), and tissue inhibitors of metalloproteinases
(TIMPs) [227,228]. Matrix metalloproteinases (MMPs) are a family of at least 20 zinc endopep‐
tidases that take part in the regulation of cell matrix composition by cleaving basal lamina and
ECM proteins. MMPs can be secretory or cell surface bound. Under normal conditions, MMP
activity is required for tissue remodeling, but altered MMP activity has been reported in
disease. Most MMPs are secreted as inactive pro-proteins but get activated when cleaved by
extracellular proteinases. Interestingly, one of the targets of MMP activity is the ECM mole‐
cules in BrM.
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It has been shown that relatively small dysregulation in the relative production of MMPs,
TIMPs, and collagen types I and IV [227,228] may lead to net changes in the ECM, including
thickening and deposit formation [228,231]. Accordingly, dysregulated turnover of ECM is a
major mechanism of disease pathogenesis in many tissue sites, including renal disease,
atherosclerosis, lung disease, and others [228-231]. Unfortunately, minimal information is
available concerning normal turnover in healthy BrM or imbalanced turnover in AMD.
Ample evidence supports the idea that MMPs and their tissue inhibitors TIMPs play an
important role in AMD. The RPE is capable of producing many ECM components such as
MMP-2, MMP-14, Basigin, also known as EMMPRIN (extracellular matrix metalloproteinase
inducer) or CD147, collagen, and TIMP-2 [56,171,232, 233]. MMP-2 and MMP-14 are the major
RPE enzymes synthesized for the degradation of matrix type IV and I collagens, laminin, and
fibronectin, which are components found in BrM [232,233]. MMP-2 is the key enzyme for ECM
turnover in BrM and is synthesized as an inactive zymogen pro form (pro-MMP-2) [227]. The
transmembrane metalloproteinase MMP-14 is well known to activate MMP-2 in a specific
manner [233]. On the other hand, TIMP-2 may inhibit the cleavage of pro-MMP-2 into MMP-2
[228]. Based on these data our research focuses on MMP-2, MMP-14, basigin, and TIMP-2 and
propose that dysregulation of MMP-2 is the primary cause for the accumulation of sub-RPE
deposits that become BLD and drusen. Thus, preservation of RPE-derived MMP-2 function
will prevent these events.
As mentioned before, oxidative injury to the RPE may not only produce blebbing but also
dysregulated ECM turnover [5,46,47,206,234,235]. Our group has demonstrated that nonlethal
oxidant injury to the RPE with hydroquinone induces a wide range of changes in gene
expression, especially for those genes involved in regulation of ECM [47], and that blebs form
and accumulate in the absence of activated MMP-2, which otherwise induce breakdown of
types I and IV collagen present in the basement membrane of the RPE [235]. Sustained oxidant
injury with hydroquinone is capable of downregulating MMP-2 activity in an in vitro system
of RPE cells, correlating with an increase in bleb levels [56,171]. Also, type IV collagen
accumulation, the main component of the RPE basement membrane, correlated with the
absence of MMP-2 activity [56]. Accordingly, we have shown in vivo [235] that reducing
MMP-2 activity leads to an increase in deposit formation by RPE cells. This allows the blebs
to become trapped between the RPE cell membrane and the basement membrane to form BLD.
For the BLD deposits to progress into linear deposits ECM upregulation with MMP-2 activa‐
tion is necessary for collagen and BLD deposit degradation. This will ultimately displace sub-
RPE deposits into the inner layer of BrM where BLinD and drusen are histologically found.
As proposed in our hypothetical model fro dry AMD, RPE-derived blebs accumulated as BLD
could stimulate RPE basement membrane breakdown allowing the migration of BLD and
buildup of BLiD or drusen. We postulate that various plasma-derived molecules related to
systemic health cofactors (i.e., Ang II) are implicated in this stage.
As an attempt to better understand the mechanisms involved in early AMD, we investigated
the proteomic profile of RPE-derived blebs induced by hydroquinone. Interestingly MMP-14
and basigin were identified in the RPE blebs [236]. Both proteins are of special relevance to the
AMD pathology as they promote MMP-2 activation. Basigin, is a pleiotropic transmembrane
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glycoprotein [236,239]. The basigin gene (BSG) encodes for a 29 kDa protein which is prone to
glycosylation increasing its molecular weight between 35 and 65 kDa [238-240]. Induction of
matrix MMPs constitutes the most relevant function of basigin [240, 242-244]. A clear require‐
ment for basigin to be glycosylated exists for MMP induction [245-247]. The fact that basigin
is a prominent MMP inducer provides this protein with a putative role in normal tissue
remodeling physiology and ECM pathologies other than cancer. In particular, glycosylated
basigin has been reported to be necessary for maturation of the retina photoreceptor cells [248].
Within the mature eye, basigin is expressed in the RPE, Mueller cells, and in endothelial cells
of blood vessels [249-252]. A known mechanism by which basigin increases the MMPs occurs
at transcriptional level [253, 254]. However, shedding of basigin from the plasma membrane
constitutes an additional regulatory mechanism recently proposed where basigin is transport‐
ed in microvesicles which are later on degraded, releasing soluble, active basigin [255]. This
proposed mechanism may permit basigin to exert its actions at distant sites. MMP-14 is an
interesting candidate responsible for the basigin shedding [256-258]. Based on the cited
evidence, we hypothesize a mechanistic model by which basigin and MMP-14 are carried to
distal sites from the RPE where they exert their actions promoting MMP-2 activity. In addition,
MMP-14 may interact with basigin releasing fully functional “soluble” basigin (Fig. 10).
Figure 10. Mechanistic model by which basigin and MMP-14 are carried to distal sites from RPE where they exert their
actions promoting MMP-2 activity.
We reported the presence of glycosylated basigin and MMP-14 in blebs, which was con‐
firmed by Western blot and immunofluorescence staining in human control and AMD retinas
(Fig. 11) [179]. Basigin and MMP-14 were confined to the RPE in normal retina, while it was
widely expressed in AMD retina. In addition, our data showed that RPE cells incubated with
blebs exhibit increased active MMP-2. MMP-2 activity returned to basal levels after incuba‐
tion with anti-basigin and MMP-14 antibodies (Figure 10), suggesting that both proteins may
play a pivotal role determining MMP-2 activity [179]. Thus, blebs accumulated under the
RPE will stimulate ECM turnover increasing active MMP-2 through the action of two bleb-
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carried  proteins,  basigin  and  MMP-14.  Therefore,  we  speculate  that  blebs  may  play  an
important  role  for  sub-RPE to traverse RPE basement membrane.  RPE are subsequently
stimulated  to  increase  synthesis  of  collagens  and  other  molecules  responsible  for  ECM
turnover,  affecting  both  RPE  basement  membrane  and  BrM.  This  process  leads  to  the
formation of new basement membrane under the RPE to trap these deposits within BrM. We
postulate that various hormones and other plasma-derived molecules related to systemic
health cofactors are implicated in this stage.
Figure 11. Immunohistochemical analysis of basigin and MMP-14 in human retina. Retina sections from human donor
eyes with no known eye disease (A, C, and E) or from human donor eyes with dry AMD (B, C, and F) were stained with
either mouse polyclonal anti-basigin (C and D) or mouse monoclonal anti-MMP-14 (E and F) as indicated. Negative
controls were generated by omission of the primary antibody (A and B). Secondary antibodies were coupled to Alexa
Fluor 488. Nuclei were stained with 4,6-diamidino-2-phenylindole dihydrochloride. Sections were analyzed under a
confocal microscope. INL, inner nuclear layer; ONL, outer nuclear layer; PIS, photoreceptor inner segments; POS, pho‐
toreceptor outer segments; Ch, choroi.
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8. Inflammation and angiogenesis
8.1. Inflammation: Role of cigarette smoke and angiotensin II
Another potential oxidative injury stimulus in AMD may occur during inflammation.
Histopathology of AMD demonstrates that all stages of the disease, including drusen,
geographic atrophy and CNV, are associated with inflammatory cells, especially macrophages
[24,25,37,259,260]. One well-characterized inflammatory oxidant is myeloperoxidase (MPO),
a heme protein secreted by neutrophils and macrophages that converts its substrate hydrogen
peroxide into an active oxidant [206]. RPE metabolism results in high quantities of hydrogen
peroxide synthesis, which by itself is a weak oxidant and is neutralized by catalase and other
anti-oxidant enzyme systems [261-263]. However, in the setting of MPO release, RPE-derived
hydrogen peroxide can become a powerful oxidant [171]. Macrophage-derived MPO will
remain extracellular, but may initiate or potentiate the RPE injury response by catalyzing
hydrogen peroxide into the formation of powerful oxidants such as hydroxyl radicals,
hydroperoxides, hypochlorous acid, and tyrosyl radicals [50,264]. Among their actions, MPO-
derived oxidants induce injury to the cell membrane and modify cell surface proteins and
receptors [50,265,266].
Data from a number of laboratories provide compelling evidence that inflammatory and/or
immune-mediated events may participate in the development of sub-RPE deposits formation
and/or progression to CNV [12,24, 267-269]. Based upon available data, a new paradigm has
been introduced for sub-RPE formation and its relationship to AMD. This integrated hypoth‐
esis is based largely upon the dynamic interactions between those factors that induce and
sustain chronic local inflammation at the level of the RPE-BrM-choroidal interface, and those
mechanisms that attenuate it. Complement and immune complexes have been identified in
drusen, but their pathogenic role has not been defined. This information has been recently
reviewed [24-27]. Other investigators have observed that choroidal monocytes/ macrophages
are present in human specimens of both early and late AMD [24,25,27,37,259,270]. Macro‐
phages have been detected along the choriocapillaris-side of BrM underlying areas of thick
drusen or other deposits [10, 260-273] and processes from choroidal monocytes have been
noted to insert into BrM deposits [260] Moreover, dentritic cells are often observed in the sub-
RPE space in association with whole, or portions of, RPE cells that have been shunted into
BrM, prior to the time that drusen are detectable. Therefore, macrophages and choroidal
dentritic cells may be activated and recruited by locally damaged and/or sublethaly injured
RPE cells. This idea is consistent with the data showing that macrophages and/or dentritic
cells, and thus the innate immune system, can be activated by microenvironmental tissue
damage [14,274,275]. However it remains to be determined whether drusen-associated
macrophages and dentriric cells initiate a classical immune response involving T helper cells,
secreted cytokines, elicit an inflammatory or complement-mediated response, or play some
other role in the generation of drusen.
While it is largely recognized that macrophages accumulate in AMD lesions, there is ambiguity
surrounding their role in the disease process with conflicting evidence regarding whether they
might be helpful by scavenging accumulated debris and therefore protecting against CNV or
harmful by stimulating CNV [100]. This might be due to the largely observational nature of
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human samples but also probably reflects different functions macrophages serve during
distinct phases of the disease.
Inflammation is a complex process that involves local secretion of pro-inflammatory cytokines
(leukocyte adhesion molecules, ICAM-1 and VCAM-1) [276,277], MCP-1 [278-282] NFκB
[283-285], and growth factors (tumour necrosis factor, TNF-α, TGF-β). The key inflammatory
molecule in initiating inflammatory responses may be MCP-1 [278-284] a powerful chemokine,
expressed at sites of injury. Indeed, the importance of MCP-1 in inflammatory diseases is
highlighted by a careful MEDLINE search for MCP-1, which readily returns more than 3000
citations following its characterization in the late 1980s. NFκB appears to control expression
of MCP-1 [283-285]. After release, it activates the CCR2 chemotactic receptor to induce
chemotactic responses that mediate monocyte and macrophage migration into sites of active
inflammation in various diseases [286,287].
Based upon the assumption that injured RPE may serve as stimulatory factors that initiate
macrophages recruitment and activation, it was determined if monocyte populations from
individual AMD patients exhibited heterogeneity in terms of cytokine production in culture
or in mRNA expression of freshly isolated cells, and if high levels served as a biomarker of
risk for progression into neovascular AMD [51]. TNF-α expression, a potent cytotoxic and
proangiogenic cytokine for wet AMD. Typically human macrophages in culture, after
stimulation with RPE derived blebs produced an increase in TNF-α. However, extremely high
variability in baseline TNF-α expression from isolated macrophages was observed among
different subjects [51]. These results are consistent with the hypothesis that the pre-existing
macrophage activation state, defined as level of cytokine or mediator expression of the
circulating monocyte, might determine the negative or positive consequence of macrophage
recruitment as a disease modifier. Macrophages with low expression might remove deposits
safely whereas macrophages with high expression might produce mediators that contribute
to disease progression.
As mentioned above, aberrant expression of chemokines occurs in a variety of diseases that
have an inflammatory component. Highly specialized RPE cells play a pivotal role in the
maintenance of the outer retina by secreting several cytokines including monocyte chemoat‐
tractant protein-1 (MCP-1) [288,289] which has been suggested to be implicated in the
pathogenesis of AMD [290,291]. RPE cells can secrete MCP-1 in the direction of choroidal blood
vessels during inflammatory responses therefore suggesting that RPE cells might promote
macrophage recruitment to the choroid from circulating monocytes [292]. It was reported that
MCP-1 is regulated in injured ARPE-19 cells and that free radicals might be immunostimula‐
tory [293] providing support for the notion that injured RPE cells may induce monocyte
migration.
We have investigated MCP-1 expression in RPE from patients with AMD as well as the
regulation of RPE-derived MCP-1 expression following cigarette hydroquinone-mediated
oxidative injury. Our data report for the first time that MCP-1 expression is markedly de‐
creased in RPE from smoker patients with AMD [294] thereby pointing to a critical role for
MCP-1 in the pathogenesis of the disease. We acknowledge that due to the nature of our study,
it cannot be determined whether the altered expression of MCP-1 in human RPE lysates is a
cause or consequence of the disease. However, our current findings suggest that declining
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MCP-1 production by aging RPE cells may impair recruitment of macrophages/dentritic cells
essential for scavenging debris which may lead to drusen formation and accumulation in AMD
patients. It can be speculated that declining RPE-derived MCP-1 production resulting from
cumulative exposure to oxidative damage may be an important factor that could accelerate
and promote the formation of sub-RPE deposits in smokers. This theory is put forth bearing
in mind the complexity of underlying cellular and molecular mechanisms involved in the
inflammatory response and with the acknowledgment that numerous AMD genotypes may
exist. Therefore, we fully recognize that only some aspects of the proposed hypothesis may be
involved in any given AMD genotype.
Based on the above hypothesis, we have evaluated the possibility that hydroquinone-induced
oxidative stress might regulate MCP-1 expression in the RPE. We showed that prolonged
exposure to hydroquinone-induced oxidative injury downregulated MCP-1 production by
ARPE-19 cells and RPE/choroids from C57BL/6 mice [294]. An earlier study by Joly et al is in
line with our observations showing a decline in MCP-1 gene expression in retinas of mice
exposed to light-induced oxidative damage for several days [294]. Our observations suggest
that sustained exposure to hydroquinone might impair RPE-derived MCP-1-mediated
scavenging macrophages and dentritic cells recruitment and phagocytosis which might lead
to incomplete clearance of proinflammatory debris trapped between the RPE and its BrM. On
the other hand, our preliminary date show that RPE-derived blebs activate RPE MCP-1
production (unpublished data), suggesting that when significant BLD will have already
formed, RPE-blebs and other debris will activate MCP-1 secretion by RPE leading to infiltration
of proangiogenic macrophages to sub-RPE deposit areas, where they will scavenge, relate more
cytokines and mediators, and amplify the process leading to progression of drusen to CNV in
smoker patients with AMD.
Angiotensin II is not only a potent vasoconstrictor which elevates arterial blood pressure, but
also a powerful pro-inflammatory cytokine, chemokine and growth factor [276, 283-285,295],
which mediates the activation of inflammatory mechanisms involved in age-related diseases
[296,297]. There is accumulating evidence that Ang II can cause target organ damage by
facilitating inflammatory and growth responses through activation of NFκB [276, 283-285], the
key nuclear transcription factor in inflammatory and fibrotic diseases. Activation of NFκB by
Ang II may stimulate transcription of numerous inflammatory genes, including MCP-1,
RANTES (Regulated on Active Normal T cell Expressed and Secreted) and interleukin (IL)-6,
TNF-α and TGF-β [276,283-285]. The view that MCP-1 is one of the most important chemokines
in Ang II-induced inflammatory responses is supported by numerous studies, although the
mechanisms by which Ang II increases MCP-1 expression and production are still not well
understood [279,283-285]. In a rabbit model of atherosclerosis, ACE1 inhibitor quinapril
inhibited NFκB activity, expression and production of MCP-1 and neointimal macrophage
infiltration at the injured sites [283]. In Ang II-induced hypertensive rats, vascular MCP-1
mRNA expression increased almost four-fold, which was significantly reduced by normali‐
zation of hypertension by the non-specific vasodilator hydralazine, but the effects of AT1
receptor blockade were not studied [301]. However, in a different study, Ang II enhanced
expression of MCP-1 mRNA and protein production in rat vascular smooth muscle cells in a
dose- and time-dependent fashion, and these effects were mediated by AT1 receptors involv‐
ing the Rho-kinase pathway [298]. In mice, Wu et al. [299] showed that the AT1 receptor
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antagonist valsartan, at a dose that did not influence systolic blood pressure, significantly
reduced the expression of MCP-1 along with other inflammatory genes such as TNF-α, IL-6,
IL-1β and monocyte/macrophage infiltration in injured vessels. Interestingly, the effects of
valsartan on MCP-1 expression were attenuated in AT2 receptor-deficient mice, suggesting
that both AT1 and AT2 receptors are involved.The advantage of using a lower dose of AT1
receptor blockers is that the treatment does not reduce systolic blood pressure to the normo‐
tensive level, but retains clinical efficacy in inhibiting MCP-1 expression and improving cardiac
function and mortality. Accordingly, the beneficial effects of the AT1 receptor blockers may
be explained by a mechanism other than high blood pressure. A direct effect of Ang II on
MCP-1 expression and production may be implicated [295].
Finally, the signalling mechanisms by which Ang II increases MCP-1 expression and produc‐
tion and induces end-organ damage remain to be elucidated. As mentioned previously, there
is mounting evidence that NFκB may be one of the most important nuclear transcription factors
that mediates Ang II-stimulated MCP-1 expression and production [276,283-285]. However,
the signalling pathways by which Ang II directly or indirectly activates NFκB, which is then
translocated into the nucleus to mediate MCP-1 transcription and synthesis, remain largely
unknown. A local RAS may be activated in most, if not all, diseases with consequently
increased tissue or intracellular Ang II. Binding of extracellular Ang II to cell surface AT1
receptors may stimulate MCP-1 mRNA expression through activation of different intracellular
signalling cascades, likely involving protein kinase C-activated intracellular calcium mobili‐
zation [300], tyrosine kinase and mitogen-activated protein kinase [301], phospholipase A2
[302] and redox-sensitive NADH/NAD(P)H oxidase [301]. Future studies further addressing
these important issues could improve our understanding of the potential role of pro-inflam‐
matory cytokines and chemokines in mediating Ang II-induced target organ damage and assist
in further development of novel drugs to prevent and treat these diseases.
Even if it has been suggested that increased MCP-1 expression may be a key mediator between
Ang II and retinal damage in hypertensive patients, MCP-1 expression has not been investi‐
gated in RPE from hypertensive patients with AMD nor has been the regulation of RPE-derived
MCP-1 expression following Ang II-mediated injury.
On the basis of our preliminary data and those of others, we have proposed a molecular
inflammatory hypothesis for AMD that describes a central role for the redox-sensitive NF-κB
in modulating the gene expression of MCP-1. Many studies have provided experimental
evidence indicating that NF-κB can be activated by oxidative stress [303-305] and that the anti-
oxidant may have beneficial effects on vascular inflammation that occurs in other age-related
diseases [306,307]. Thus, we proposed that Ang II will active RPE MCP-1 production leading
to recruitment of macrophages to sub-RPE deposit areas, where they will scavenge, release
more cytokines and mediators, and amplify the process promoting complications, especially
CNV formation. Our preliminary data indicate that expression of MCP-1, key mediators
pertinent to inflammation is markedly increased in cultured human RPE cells in response to
Ang II (Fig. 12). Moreover, our data indicate that the increase in MCP-1 mRNA and protein
secretion by RPE was through AT1 receptors activation (Fig. 12), highlighting such pro-
inflammatory role of Ang II and their mechanism. These observations may have strong
implications for the drusen progression to CNV in hypertensive patients with dry AMD.
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Future studies addressing whether or not Ang II directly or indirectly activates NFκB and the
signalling pathways could improve our understanding of the potential role of Ang II in the
progression of dry AMD to CNV.
Figure 12. Ang II upregulated MCP-1 protein expression (A) and secretion (B) through Ang II receptor 1 (AT1) activa‐
tion in RPE cells. Human ARPE-19 cells were incubated with Ang II alone (100 nM) for 24 hours or in combination with
candesartan (CD, 100 nM), an AT1 receptor antagonist, or PD123319 (PD, 100 nM) an Ang II type 2 receptor antago‐
nist for 30 min before Ang II stimulation, then washed with PBS and incubated in assay medium (0.1% FBS) for 24
hours. Supernatants and cell homogenates were collected to assess MCP-1 mRNA expression by real-time PCR and
protein secretion by ELISA. Results are expressed as mean±SEM. **P<0.01, statistically significant difference compared
with the control
Cigarette Smoking and Hypertension Two Risk Factors for Age-Related Macular Degeneration
http://dx.doi.org/10.5772/53958
65
Because hypertension has been unequivocally linked to the pathogenesis of AMD, it can be
speculated that increase in RPE-derived MCP-1 production resulting from exposure to Ang II
may be an important factor that could accelerate and promote the progression of early AMD
to CNV. This theory is put forth bearing in mind the complexity of underlying cellular and
molecular mechanisms involved in the inflammatory response.
8.2. Angiogenesis: Role of cigarette smoke and angiotensin II
Angiogenesis is a highly complex biological process that involves a delicate balance between
numerous stimulators and inhibitors, each regulated by multiple control systems. CNV-related
angiogenesis requires an alteration in the concentration of molecules that stimulate or inhibit
growth of new blood vessels [308,309]. Vascular endothelial growth factor (VEGF) constitu‐
tively produced and secreted by RPE in culture [310-318], is a major angiogenic cytokine central
to the development of wet AMD [312-315].VEGF regulates endothelial cells proliferation,
migration and survival [315]. Interestingly, secretion of VEGF by RPE cells is polarized towards
BrM [250]. There is ample clinical evidence that VEGF expression is increased in surgically
excised AMD-associated choroidal neovascular membranes [315-317]. Eyes with early forms
of AMD have increased expression of VEGF in the RPE and the vitreous of eyes with CNV
have increased concentration of VEGF [315]. Similar observations have been made in animal
models of CNV [311,320]. Furthermore, Reich et al reported that subretinal injection of VEGF
siRNA significantly inhibited the growth of laser-induced CNV in a mouse model [318]. PEDF,
a potent angiogenic inhibitor [321] secreted by RPE cells [322-324], counterbalances the effects
of VEGF and modulates the formation of CNV [322,323]. A decrease in PEDF expression has
been reported in eyes with AMD, therefore disrupting the critical balance between VEGF and
PEDF that may lead to pathological angiogenesis and be permissive for the development of
CNV [322]. PEDF levels decline in the vitreous of patients with CNV [324].
Interestinly, TNFSF15, a cytokine that belongs to the TNF superfamily, which originally was
reported to be expressed exclusively in endothelial cells, and more recently in other several
cell types in inflammatory diseases [325-328], could be implicated in the development of CNV.
TNFSF15 is a potent inhibitor of endothelial cell proliferation, angiogenesis, and tumor growth
[329] which has been involved in atherogenesis and neovascularization. Our preliminary data
has shown constitutive TNFSF15 production and secretion by RPE in vitro and in vivo (Marin-
Castano, unpublished results). Moreover, there is recent evidence showing down-regulation
of TNFSF15 by VEGF in endothelial cells, therefore disrupting the critical balance between
TNFSF15 and VEGF and leading to development of neovascularization [330]. Based on this
recent evidence, it is conceivable that the balance between TNFSF15 and VEGF could be of
great importance in CNV development. However, until now, there is no report in the literature
examining VEGF, PEDF, and TNFSF15 expression in RPE from AMD patients or evaluating
whether or not cigarette smoke-related hydroquinone and nicotine and Ang II have the
potential to dysregulate the VEGF/PEDF and VEGF/TNFSF15 balance in RPE cells.
Given the critical role of VEGF and PEDF in AMD and that oxidative damage to the RPE and
angiogenesis appear to be central in the pathogenesis of the disease; we studied the expression
of these chemokines in RPE from smoker patients diagnosed with AMD and whether cigarette
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smoke-derived hydroquinone and nicotine might also regulate VEGF and PEDF expression in
RPE cells.
We report that VEGF expression is increased and PEDF expression is decreased in RPE from
smoker patients with AMD resulting in an increased VEGF-to-PEDF ratio [282]. A disruption
in the critical balance of these opposing stimuli may be permissive for the development of wet
AMD. Our findings are consistent with clinical observations describing dysregulated expres‐
sion of VEGF and PEDF [315-317,321,322,324] in eyes with AMD. Oxidant-mediated RPE
damage might promote abnormal angiogenesis [309]. In vitro, although oxidative injury
declined the production of PEDF without significantly changing VEGF expression in ARPE-19
cells regardless of dose and duration of exposure to hydroquinone, we observed an increased
VEGF-to-PEDF ratio which may favor angiogenesis [282]. These results suggest that cigarette
smoke-related HQ-induced oxidative stress might impair the delicate balance between VEGF
and PEDF that controls angiogenic homeostasis in the retina. Other previous reports showed
that cigarette smoke extract induces VEGF expression in ARPE-19 cells [104] and that H2O2-
induced oxidative stress increased the production of VEGF in human RPE cells [309]. The
discrepancy between our in vitro findings and those earlier observations with regards to VEGF
might reflect differences in cellular responses in the setting of different types of oxidant-
mediated injury.
The endogenous angiogenic inhibitors are believed to be essential for maintaining the
homeostasis of angiogenesis in the retina. Given the evidence that PEDF is an important
negative regulator of angiogenesis, lower levels of PEDF is strongly suggestive of a decreased
anti-angiogenic activity that may lead to the initiation of angiogenesis in response to hydro‐
quinone-induced oxidative stress. However, we do not rule out the possibility that a decreased
level of inhibitory factor PEDF by itself may not be sufficient for inducing the angiogenic switch
leading to CNV. Reciprocal increase in stimulatory VEGF might also be needed. In fact, a longer
more sustained exposure to hydroquinone might be necessary to induce VEGF expression in
ARPE-19 cells. Furthermore, angiogenesis is a highly complex and tightly orchestrated
multistep process involving extensive interplay between multiple angiogenic factors. It is
therefore possible that several other molecules besides VEGF and PEDF regulated by hydro‐
quinone might permit the development of abnormal angiogenesis. In vivo, we observed
elevated expression of VEGF and PEDF protein in RPE/choroids from HQ-treated mice which
translated into an enhanced VEGF-to-PEDF ratio. As stated earlier, important species-specific
differences may also account for the discrepancy between human cells and mice results. In
addition, one has to keep in mind that inherent in vitro and in vivo differences might explain
this disparity. PEDF has multiple dose-dependent biological functions. Interestingly, it has
been reported that low doses of PEDF are inhibitory but high doses can increase the develop‐
ment of CNV induced by laser in mice [331]. In addition, a study showed that RPE-derived
VEGF upregulates PEDF expression via VEGF receptor-1 in an autocrine manner [332],
therefore highlighting regulatory interactions between these two counterbalancing systems of
angiogenic stimulators and inhibitors. In any case, our in vivo findings confirm that hydro‐
quinone-induced oxidative damage is unequivocally associated with an imbalance between
VEGF and PEDF in the RPE.
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We also studied whether Nicotine (NT), a potent angiogenic agent abundant in second hand
smoke, play a major role in the pathogenesis of wet AMD. The purpose of this study was to
evaluate the expression of nicotinic acetylcholine receptors (nAchR) in the RPE and determine
the effects of NT on RPE-derived VEGF and PEDF expression in the context of passive smoking.
We demonstrated that cultured RPE cells constitutively expressed nAchR α3, α10 and β1
subunits, β1 being most prevalent (Fig. 13). nAchR α4, α5, α7 and β2 subunits were detected
in RPE sheets from rats, among which α4 is the predominant subtype (Fig. 14). NT which did
not, induced β1 nAchR, upregulated VEGF and downregulated PEDF expression through
nAChR in ARPE-19 cells (Fig. 15). Moreover, transcriptional activation of nAchR α4 subunit
and nAChR-mediated upregulation of VEGF and PEDF were observed in RPE from rats
exposed to NT [333]. Our findings confirm that NT is associated with an increased VEGF-to-
PEDF ratio in RPE through nAchR in vitro and in vivo which may play a key role in the
progression to wet AMD in passive smokers [333].Taken together, these data provide strong
support for a key role played by hydroquinone and NT-injured RPE cells in the progression
of dry AMD to CNV. We demonstrated that RPE dysfunction might lead to dysregulation of
macrophage clearance function and angiogenic homeostasis as a result of oxidative damage
which may trigger progression towards CNV in smoker patients with dry AMD.
As mentined previously, hypertension has been associated with the development of wet AMD
in the presence of early AMD [128]. These studies make no mention of the mechanism(s) by
which hypertension may induce or contribute to the progression from early AMD to CNV.
Some investigators have shown that Ang II contributes to to pathological conditions such as
neovascularization, atherosclerosis, and tumor [334-340]. Moreover, it has been shown that
Ang II-induced angiogenesis is mediated by VEGF receptor-1 [341] and that Ang II type 2
receptor inhibits VEGF-induced migration and in vitro tube formation of human endothelial
cells [342]. However, nothing is known about the regulation of TNFSF15 by Ang II in any of
the tissues where it is expressed. Therefore, investigating the regulation of TNFSF15 by Ang
II helped us to understand how regulation of this cytokine by Ang II could participate in the
development of neovascularization in wet AMD patients with HTN. We hypothesize that
hypertension through Ang II will alter the secretion of TNFSF15 release by the RPE, which
may contribute to an imbalance between VEGF and TNFSF15 leading to CNV development.
Our preliminary data showed that Ang II diminishes release of TNFSF15 by RPE cells through
activation of both Ang II receptor subtypes and increases release of VEGF by RPE cells through
activation of the AT2 Ang II receptor subtype (Marin-Castano, unpublished data), which might
permit the development of abnormal angiogenesis contributing to CNV. Our study may result
in the identification of TNFSF-15 as an important target to inhibit the initiation of CNV and in
Ang II receptors blockade as therapeutic preventive strategy
9. Animal model for dry AMD
Animal models are extremely useful in preclinical testing of theories of disease pathogenesis
and can serve to question current hypotheses and predict outcomes of therapeutic interven‐
tions. Our laboratory and others have used the C57BL/6 mouse model to evaluate mechanisms
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for age, gender, diet, environmental toxins, and to text hypothesis [46,55,60,343]. Until recently,
no animal models for dry AMD were available. The only available model for dry AMD and
hypertension was reported by Jonas et al in 2003 [124].
Figure 13. Human RPE cells constitutively express α3, α10 and β1 nAchR subunits. Real-time PCR demonstrated the
presence of nAchR α3, α10 and β1 subunits transcripts and the prevalence of β1 subtype in confluent serum-starved
(A, B, E, G, H) ARPE-19 and (C, D, E, G, H) human primary RPE cells. GAPDH was used as housekeeping gene. Real-time
PCR for (E) β1, (G) α3 and (H) α10 nAchR was followed by ethidium bromide-stained agarose gel electrophoresis to
visualize the products in ARPE-19 and primary RPE cells. Shown is a representative gel. Number on the left represents
size of transcript in base pairs (bp). (F) Western blot analysis demonstrated the expression of the most prevalent
nAchR β1 subunits in confluent serum-starved ARPE-19 and primary RPE cells. Shown is a representative gel. Number
on the left represents protein molecular weight in kilodaltons (kDa).
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Based on the idea that hydroquinone and arterial hypertension might influence the develop‐
ment and severity of drusen, we extended our in vitro data to a more physiological environ‐
ment using; a) the 16-month-old or b) the 9-month-old C57BL/6 mouse model for dry AMD
published by our laboratory [46,55,60,343], but providing an alternative source of oxidant
stimulus by replacing exposure to blue light with exposure to hydroquinone in food [55] or
drinking water [56] for 4.5 months or with Ang II alone or in combination with the AT1 receptor
antagonist (candesartan) or the AT2 receptor antagonist (PD123319) for 4 weeks or 3.5 months.
In addition, all mice received a regular fat diet instead of high-fat diet. We evaluated the impact
of these compounds on the development of sub-RPE deposits, by using TEM.
As published previuosly, hydroquinone-treated mice had increased blood levels of hydroqui‐
none relative to control mice that showed non detectable levels [56]. Mice not exposed to
hydroquinone showed normal morphology of the RPE, BrM, and choriocapillaris endothelium
(Fig. 16A). Some specimens demonstrated mild frequency of any BLD. None of the eyes in this
Figure 14. RPE from rats constitutively express α4, α5, α7 and β2 nAchR subunits. Real-time PCR demonstrated the
presence of nAchR α4, α5, α7 and β2 subunits transcripts (A-D) and the prevalence of α4 subtype (B-D) in RPE from
Sprague-Dawley rats (pooled RNA from 5 rats/lane). Real-time PCR for α4, α5, α7 and β2 nAchR isoforms was followed
by ethidium bromide-stained agarose gel electrophoresis to visualize the products (A). Shown are a representative
gels. Number on the left represents size of transcript in base pairs (bp). *** is p<0.0001.
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group demonstrated moderate BLD. Animals exposed to hydroquinone showed pathologic
changes in the RPE and BrM characterized by moderate BLD [56]. Approximately a 83% of
eyes exhibited moderate BLD. The BrM was thickened, with coated vesicles, membranous
profiles, and banded structures, Figs. 16B, 16C ), typical of those described in some human
AMD specimens [46]. Findings were of a magnitude similar to those previously observed in
mice exposed to high-fat diet plus blue green light [62]. Interestingly, animals showed blebs
Figure 15. NT increased VEGF expression and decreased PEDF expression through nAchR in ARPE-19 cells. NT (A) in‐
creased VEGF and (C) decreased PEDF mRNA expression in ARPE-19 cells. Confluent serum-starved ARPE-19 cells were
treated with NT 10-8M for 72 hours. Total RNA was extracted to assess VEGF and PEDF mRNA expression by real-time
PCR. GAPDH was used as housekeeping gene. NT (B) increased VEGF and (D) decreased PEDF protein expression. Con‐
centration of VEGF and PEDF secreted in supernatants of confluent serum-starved ARPE-19 cells treated with NT 10-8M
for 72 hours was assessed by ELISA. (E) NT increased VEGF/PEDF protein ratio. NT-induced (F) upregulation of VEGF
and (G) downregulation of PEDF mRNA expression was abolished by hexamethonium (HXM). Confluent serum-
starved ARPE-19 cells were pre-incubated with HXM 10-5M for 1 hour then exposed to NT 10-8M for 72 hours. Total
RNA was extracted to assess VEGF and PEDF mRNA expression by real-time PCR. GAPDH was used as housekeeping
gene. Data are expressed as means ± SE and represent the average results of 3 to 4 independent experiments run in
duplicate.* is p<0.05 and *** is p<0.0001 versus control; # is p<0.01 and & is p<0.05 versus NT alone.
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(Fig. 16C). In preliminary experiments, we have also demonstrated that mice receiving
subconjunctival injections of hydroquinone exhibeted a rudimentary form of BLD, often
demonstrating small vesicular vesicles bleblike structures (Reinoso, et al. IOVS 2005;46:ARVO
E-Abstract 3010). In addition, RPE from mice exposed to hydroquinone in drinking water
showed increased levels of phosphorylated Hsp25, p38 and ERK [205], suggesting that
phosphorylated Hsp25 might be a key mediator in early cellular events associated with actin
reorganization and bleb formation involved in sub-RPE deposits formation.
Figure 16. Transmission electron microscopy of the outer retina and choroid from a 16-month-old female mouse fed
with a regular fat diet for 4 months. (A) Outer retina and choroid of a mouse fed a regular diet without oxidant
showed a normal RPE, BrM, and choriocapillaris. (B) Outer retina and choroid of a mouse fed a regular diet and ex‐
posed to HQ (0.8% for 4 months) in drinking water revealed sub-RPE deposits characterized by accumulation of mod‐
erately severe BLD with dense granular material between the RPE and its basement membrane (*), compatible with a
high mean severity score. The specimen, also, shows the abnormal choriocapillaris endothelium with increased thick‐
ening and loss of fenestration. (C) TEM of the outer retina and choroids from another 16-month-old female mouse fed
a regular diet and exposed to HQ. The specimen shows moderately thick BLD with bandes structures (*) and occasion‐
al blebs (black arrows). CC, choriocapillaris, Magnification: (A, C) x25,000; (B) x7,200.
We used Ang II to determine whether hypertension-associated Ang II was important for ECM
regulation in RPE and the development of sub-RPE deposits. We reported that Ang II-treated
mice had increased blood pressure as well as plasma and ocular levels of Ang II relative to
control mice [60]. Ang II also regulated AT1a and AT1b receptor mRNA expression, and the
intracellular concentration of calcium [Ca2+]I, showing that Ang II AT1 receptor is functional.
In addition, MMP-2 activity, and type IV collagen accumulation were regulated by Ang II.
Concurrent administration of Ang II with the AT1 receptor blocker prevented the increase in
blood pressure and rise in ocular Ang II levels, as well as the calcium and MMP-2 responses.
In contrast, the type IV collagen response to Ang II was prevented by blockade of AT2
receptors, but not AT1 receptors. Plasma Ang II levels were not modified by the AT1 or AT2
receptor blockade. In addition, Ang II stimulates MMP-14, basigin, and phosphorylation of
ERK, p38, and JNK in RPE sheets from mice. These effects were mediated by Ang II type 1
receptors [344].
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Animals exposed to Ang II for 3.5 months revealed moderate BLD deposits. Sub-RPE changes
were characterized by accumulation of moderately dense homogeneous material between the
RPE and its basement membrane (Marin-Castano, unpublished data). Given that the Ang II
receptors in rodents are similar to human Ang II receptors, our study help to elucidate the
mechanism(s) by which Ang II receptor blockers may prevent these ECM changes important
for early AMD development and provide a potential future clinical tool for the prevention of
AMD. Moreover, our observations indicate that Ang II may induce the development of BLD.
Thus, the results suggest the role for Ang II in ECM turnover and sub-RPE formation and
propose Ang II-induced hypertension as an injury stimulus to the RPE, which may serve to
explain the mechanisms that underlie pathologic BLD deposits in early AMD.
Taken together, these observations indicate that different oxidant stimuli (i.e., blue light,
hydroquinone, and Ang II) may induce a common response in the RPE and that a high-fat diet
is not an absolute requirement for the development of BLD. Thus, the results suggest the role
for blebs in sub-RPE formation and propose hydroquinone and Ang II another oxidative injury
stimulus to the RPE, which may serve to explain the mechanisms that underlie pathologic BLD
deposits in early AMD.
10. Conclusions
In summary, we postulate that cigarette smoke-related and Ang II play a role in the develop‐
ment of dry AMD and its progression to wet AMD. Although our hypothesis remains to be
proven, we have proposed new ideas and suggested different mechanisms highlighting
Hsp27, MMP-2, basigin, MMP-14, MCP-1, MAPK, and TNFSF15 as potential disease-related
proteins as well as biochemical pathways for potential therapeutic strategies, which might
result in prevention of more severe and irreversible late stages of this dreadful disease. Our
goal is to intervene promptly in the early stages of the disease so that progression to the more
severe late forms of AMD can be prevented. In this respect, RPE-derived MMPs and blebs
formation are potential target due to their pivotal role in stimulating drusen formation and
progression into CNV. Levels of phosphorylated Hsp27, glycosilated basigin and MMP-14, as
well as, MCP-1 and TNFSF15 could be markers, which may contribute and aid to the ophthal‐
mologic community in the management of the drusen. Moreover, AT1 receptor antagonists
and p38/ERK1/2 MAPK blockers could be used successfully on the prevention of sub-RPE
deposits formation in selected high-risk AMD patients.
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